Use of the NEWS2 score in clinical outcomes of hospitalized COVID-19 patients by disease severity treated with remdesivir
Por:
Shah, P, Viladomiu, AS, De Castro, N, Assoumou, L, Raffi, F, Arber, N, Rokx, C, Bakhai, A, Mateu, L, Bermejo, CL, Estrada, V, Fabregas, AC, Sellier, PO, Duffy, A, Fletcher, C, Mozaffari, E, Haubrich, R, Hodgkins, P and Pozniak, A
Publicada:
1 oct 2021
Resumen:
Filiaciones:
Shah, P:
Chelsea & Westminster Hosp, Chelsea & Westminster Hosp NHS Fdn Trust, London, England
Viladomiu, AS:
Hosp Clin Barcelona, Barcelona, Spain
De Castro, N:
Hop St Louis, AP HP, Paris, France
Assoumou, L:
INSERM, Paris, France
Raffi, F:
CHU Nantes, Nantes, France
Arber, N:
Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
Rokx, C:
Erasmus MC, Rotterdam, Netherlands
Bakhai, A:
Barnet Hosp, Royal Free London NHS Fdn Trust, London, England
:
Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
Bermejo, CL:
Hosp Univ 12 Octubre, Madrid, Spain
Estrada, V:
Hosp Clin San Carlos IdiSSC, Madrid, Spain
Fabregas, AC:
Hosp Univ Vall dHebron, Barcelona, Spain
Sellier, PO:
Hop Lariboisiere, AP HP, Paris, France
Duffy, A:
Res Org Kings Cross, London, England
Fletcher, C:
Res Org Kings Cross, London, England
Mozaffari, E:
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
Haubrich, R:
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
Hodgkins, P:
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
Pozniak, A:
Chelsea & Westminster Hosp, Chelsea & Westminster Hosp NHS Fdn Trust, London, England
|